Academic clinical fellowships in Clinical (Medical) Oncology
Academic Unit of Clinical Oncology
The Academic Unit of Clinical Oncology comprises Professor Robert Coleman, Professor Janet Brown, Dr Robinson (Reader), Dr Ingunn Holen (Non-Clinical Reader) Dr Danson and Dr Chantry (Senior Clinical Lecturers). The unit is supported by programme funding from Yorkshire Cancer Research (YCR) and the Weston Park Hospital Cancer Charity. We host the Sheffield Experimental Cancer Medicine Centre which has programme funding from the Department of Health and Cancer Research-UK (CR-UK).
The academic unit has excellent infrastructure for delivery of research training. For basic medical science, there are extensive facilities for molecular biology, tissue culture, genetics, microarray and proteomics and confocal imaging. We are part of the YCR/CR-UK Cancer Research Centre in Sheffield, which supports a number of clinical and non-clinical training fellowships across the University.
Clinical Oncology has close links with the Institute for Cancer Studies (Director, Professor Mark Meuth) in the Medical School, and other research groups in the Department of Oncology, including Vascular targeting and angiogenesis – Professor Tozer, Professor Brown; Bone oncology – Dr Holen.
Clinical research is based in the Cancer Clinical Trials Centre, adjacent to Weston Park Hospital, on the main Sheffield University and hospitals campus. It is a purpose built clinical research building, with unsurpassed facilities and over 40 specialist staff supporting a wide portfolio of cancer clinical trials throughout the Trust and North Trent Cancer Network. There are close links with the National Cancer Research Institute (NCRI) and European Organisation for Cancer Treatment and Research (EORTC). Weston Park Hospital functions as the non-surgical Cancer Centre for the 1.8 million population of the North Trent Cancer Network. There are 25 consultant oncologists and 16 SpRs, all of whom participate in the cancer clinical trials programme. Subspecialty interests of the consultants span all tumour types. There are active postgraduate training programmes in both Medical and Clinical Oncology.
The unit has a strong record of research and publications. The unit has attracted grant funding from Yorkshire Cancer Research, the Department of Health, Cancer Research UK and industrial sources. Major interests include gestational trophoblastic tumours, bone oncology and breast cancer (Prof Coleman), lung cancer biology, new drugs and melanoma (Dr Danson) and developmental radiotherapy (Dr Robinson). Academic clinical fellows are usually based in the Medical School laboratories, where they can undertake projects under the joint supervision of a clinical and laboratory supervisor. Previous fellows have worked on angiogenesis, breast cancer genetics and sarcoma genetics.